PHS
IART icon

PFM Health Sciences’s Integra LifeSciences IART Stock Holding History

PFM Health Sciences’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.26M Buy
+348,746
New +$4.88M 0.54% 59
2015
Q2 		– Sell
-295,257
Closed -$7.44M – 101
2015
Q1 		$7.44M Buy
+295,257
New +$6.98M 0.21% 75

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

PFM Health Sciences's IART Position: Q2 2026 in Review

PFM Health Sciences opened a new position in Integra LifeSciences (IART) in Q2 2026: 348,746 shares worth $6.26M. The stake represents 0.54% of the portfolio and ranks #59 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in IART as recently as Q1 2015.

PFM Health Sciences first reported a position in IART in Q1 2015 and has held it in 2 quarters since. The position peaked at $7.44M in Q1 2015. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • PFM Health Sciences held 348,746 shares of Integra LifeSciences worth $6.26M as of Q2 2026.
  • Integra LifeSciences was a new PFM Health Sciences position in Q2 2026.
  • Integra LifeSciences made up 0.54% of PFM Health Sciences's portfolio in Q2 2026, its #59 holding.
  • PFM Health Sciences first reported a position in Integra LifeSciences in Q1 2015 and has held it in 2 quarters since.
  • PFM Health Sciences's Integra LifeSciences position peaked at $7.44M in Q1 2015.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.